IL2 and cancer: TG4010 is a cancer vaccine construct consisting of a recombinant, highly attenuated modified vaccinia Ankara (MVA) virus strain expressing both the human MUC1 and IL-2 genes (MVA-MUC1-IL-2) [27, 32, 33].